LIFE : Analysis & Opinions

  1. Ten Money Managers Worth Following

    December 23, 2013
    Generally speaking, most retail investors along with the media outlets tend to closely follow the moves of well-known investors ...
  2. Thermo Steps Up And Seals A Deal For Life Technologies

    April 19, 2013
    Speculation has been all over the place for an M&A with LifeTech, but the final announcement is consistent with my expectations.
  3. Has Roche Said "Nein" To Illumina's Asking Price Once More?

    January 7, 2013
    Roche may have walked away from Illumina for good.
  4. Agilent's Grim Guidance Obscures Long-Term Value

    November 20, 2012
    Agilent's guidance points to another tough year.
  5. The Week In Healthcare

    August 31, 2012
    Although this has been a solid year for med-tech, some sub-sectors are starting to lag a bit during this late summer rally.
  6. Is There Enough Growth To Really Push Life Technologies?

    June 29, 2012
    Life Technologies isn't the growth stock people think it is, but at the right price it's a good holding.
  7. Medicine Gets Personalized

    June 28, 2012
    With our population continuing to age and grow, innovation in the healthcare sector will need to move just as fast. One such ...
  8. Neogen Is Almost Cheap

    December 30, 2011
    Neogen has to do more to validate this price.
  9. Will Qiagen's Restructuring Address The Real Problems?

    November 30, 2011
    Will Qiagen's Restructuring Address The Real Problems?
  10. R&D The Future For Life Sciences Equipment Firms

    September 20, 2011
    Finding new healthcare solutions will be a paramount concern going forward. For investors, the best way to profit from this ...
  11. Affymetrix's Downward Spiral Continues

    July 7, 2011
    Affymetrix continues to flounder with unexciting technology.
  12. Should Investors Worry If Gen-Probe Doesn't Sell Out?

    June 10, 2011
    Not selling may be the best move Gen-Probe can make for its shareholders.
  13. Illumina Lights Up Again

    April 29, 2011
    Illumina is a torrid grower, and growth investors seem to be willing to pay any price.
  14. Quest Diagnostics Opens Its Wallet One More Time

    March 22, 2011
    Quest shows once again that it is willing to pay for what may become valuable testing technology.
  15. A Fistfull Of Life Sciences

    October 29, 2010
    The life sciences field is showing encouraging growth and mostly reasonable valuations.
  16. The Next-Gen Sequencing Pot Keeps Bubbling

    August 23, 2010
    Last week saw two major developments in one of the fastest-growing arenas of life science.
  17. Agile Agilent

    August 18, 2010
    Agilent may defy easy categorization, but its quality does not depend on labels.
  18. The Future of Stem Cells

    June 15, 2010
    Stem cells get a lot of attention, but maybe not in the one area where they could prove most effective.
  19. Sequencing Wars - The Third Generation

    June 10, 2010
    Life sciences companies are gearing up for a battle that could decide hundreds of millions of dollars in revenue and the ...
  20. Small Med-Tech Names You Should Know

    April 15, 2010
    These three med-tech names aren't well-known by most investors, but they should be.
  21. Ride The Goldfarb 10

    February 9, 2010
    The Goldfarb 10 are a tempting buy for value investors. Find out why.
Trading Center
You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!